🇺🇸 FDA
Pipeline program

Vonoprazan

VONO-102

Phase 1 small_molecule terminated

Quick answer

Vonoprazan for Healthy Participants is a Phase 1 program (small_molecule) at Phathom Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
Phathom Pharmaceuticals
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials